We observed elevated Rab12 phosphorylation in hippocampus and entorhinal cortex of DLB cases, as well as increased pS106-Rab12 labeling across neurodegenerative diseases with tau and/or α-synuclein pathology. This evidence concerns the gene MAPT and Lewy body dementia.